PATENT CLAIM ANALYSIS

Application Number: 15771961
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "490000"]

Abstract:
Mucus penetrating particles (MPPs) include one or more core polymers, one or more therapeutic, prophylactic and/or diagnostic agents; and one or more surface modifying agents. The surface modifying agents coat the surface of the particle in a sufficient density to enhance the diffusion of the modified nanoparticles throughout the mucosa, relative to equivalent nanoparticles that are not surface modified. Nanoparticles can be sufficiently densely coated with poly(ethylene glycol) (PEG) with a molecular weight of from 10 kD to 40 kD or greater coated with a surface density from about 0.1 to about 100 molecules/100 nm 2 , preferably from about 0.5 to about 50 molecules/100 nm 2 , more preferably from about 0.9 to about 45 molecules/100 nm 2 .

Claim (Index 12):
The mucus penetrating particles of  claim 1 , formulated with a pharmaceutically acceptable excipient for administration into or onto the body via a route selected from the group consisting of enteral, parenteral, or topical administration.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.82192
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14373324', '15207803', '15616799', '13886493', '15354704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7903354651620497
- 35 USC 102 Novelty (BERT): 0.534027081808491
- Combined Prediction Score: 0.7647046268266938
- Mean Citation Score: 327.89580599999994
- Max Citation Score: 376.80646
- Similarity Product: 303.04518123054385

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test